Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Science Translational Medicine
|
November 9, 2022
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
Nicole Kirchhammer, Marcel P Trefny, Priska Auf der Maur, et al.
International Journal of Molecular Sciences
|
February 14, 2018
Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice
Eva-Maria Rom-Jurek, Nicole Kirchhammer, Peter Ugocsai, et al.
Journal of Translational Medicine
|
August 18, 2020
A novel rabbit derived anti-HER2 antibody with pronounced therapeutic effectiveness on HER2-positive breast cancer cells in vitro and in humanized tumor mice (HTM)
Anja Kathrin Wege, Nicole Kirchhammer, Linda Veronique Kazandjian, et al.
Frontiers in Cell and Developmental Biology
|
March 21, 2022
Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer
Jinyu Wang, Michela Manni, Anne Bärenwaldt, et al.
Molecular Therapy. Methods & Clinical Development
|
March 5, 2021
iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapy
Dominik Brücher, Nicole Kirchhammer, Sheena N Smith, et al.
Cancer Immunology Research
|
August 22, 2020
Hyperglycemia Enhances Cancer Immune Evasion by Inducing Alternative Macrophage Polarization through Increased O-GlcNAcylation
Natália Rodrigues Mantuano, Michal A Stanczak, Isadora de Araújo Oliveira, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity
Laura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, et al.
Cell Reports. Medicine
|
March 25, 2021
Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack
Weldy V Bonilla, Nicole Kirchhammer, Anna-Friederike Marx, et al.
Cell Reports
|
September 26, 2019
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses
Abhishek S Kashyap, Laura Fernandez-Rodriguez, Yun Zhao, et al.
Science Translational Medicine
|
July 20, 2022
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity
Nicole Kirchhammer, Marcel P Trefny, Marina Natoli, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Science Translational Medicine
|
November 9, 2022
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
Nicole Kirchhammer, Marcel P Trefny, Priska Auf der Maur, et al.
International Journal of Molecular Sciences
|
February 14, 2018
Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice
Eva-Maria Rom-Jurek, Nicole Kirchhammer, Peter Ugocsai, et al.
Journal of Translational Medicine
|
August 18, 2020
A novel rabbit derived anti-HER2 antibody with pronounced therapeutic effectiveness on HER2-positive breast cancer cells in vitro and in humanized tumor mice (HTM)
Anja Kathrin Wege, Nicole Kirchhammer, Linda Veronique Kazandjian, et al.
Frontiers in Cell and Developmental Biology
|
March 21, 2022
Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer
Jinyu Wang, Michela Manni, Anne Bärenwaldt, et al.
Molecular Therapy. Methods & Clinical Development
|
March 5, 2021
iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapy
Dominik Brücher, Nicole Kirchhammer, Sheena N Smith, et al.
Cancer Immunology Research
|
August 22, 2020
Hyperglycemia Enhances Cancer Immune Evasion by Inducing Alternative Macrophage Polarization through Increased O-GlcNAcylation
Natália Rodrigues Mantuano, Michal A Stanczak, Isadora de Araújo Oliveira, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity
Laura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, et al.
Cell Reports. Medicine
|
March 25, 2021
Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack
Weldy V Bonilla, Nicole Kirchhammer, Anna-Friederike Marx, et al.
Cell Reports
|
September 26, 2019
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses
Abhishek S Kashyap, Laura Fernandez-Rodriguez, Yun Zhao, et al.
Science Translational Medicine
|
July 20, 2022
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity
Nicole Kirchhammer, Marcel P Trefny, Marina Natoli, et al.
Page
of 2